Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension

NCT01193101 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

389

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: LCZ696
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals